C57.3
Malignant neoplasm of parametrium
Clinical Classification Guidelines
Inclusion Terms
- Malignant neoplasm of uterine ligament NOS
Medical Intelligence & Overview
The malignant neoplasm of the parametrium, classified under ICD-10 code C57.3, refers to a type of cancer that originates in the connective tissue surrounding the uterus, known as the parametrium. This condition is also termed as malignant neoplasm of the uterine ligament, though it is often called 'not otherwise specified (NOS)' because it covers a range of possible tumor sites within this region. The parametrium includes structures such as the uterine ligaments, connecting the uterus to other pelvic structures. Though relatively rare compared to other gynecologic cancers, this malignancy warrants attention due to its potential to spread and impact surrounding tissues and organs.
Causes & Symptoms
Clinical Causes: Genetic mutations leading to abnormal cell growth Hormonal imbalances that may promote cancer development Exposure to certain carcinogens or toxins History of radiation or previous pelvic cancers Family history of gynecologic cancers Environmental factors influencing genetic susceptibility
Key Symptoms: Unusual pelvic or lower abdominal pain Pelvic mass or swelling felt during examination Abnormal vaginal bleeding or discharge Pain or discomfort during intercourse Urinary symptoms such as urgency or frequency Back pain or pressure in the pelvic area Unexplained weight loss or fatigue in advanced stages
Diagnostic & Treatment
Diagnosis Path: Diagnosing a malignant neoplasm of the parametrium typically involves a combination of clinical evaluation and diagnostic tests, including: - Pelvic examination to identify any palpable masses or irregularities - Imaging studies such as ultrasound, MRI, or CT scans to assess the extent of the tumor - Biopsy procedures to obtain tissue samples for histopathological analysis - Possible additional tests like blood work to evaluate overall health and detect tumor markers Histopathology helps determine the cancer type and grade, guiding treatment planning. Accurate imaging also assists in staging the tumor to understand how far it has spread and to simplify surgical planning.
Treatment Protocols: Treating a malignant neoplasm of the parametrium usually involves a multidisciplinary approach, tailored to the stage of the cancer and the patient's overall health. Typical treatments include: - Surgical procedures such as hysterectomy combined with removal of affected tissues and lymph nodes - Radiation therapy to target and destroy cancer cells in the pelvic area - Chemotherapy to address potential or confirmed metastatic disease - Targeted therapy or immunotherapy in select cases where specific genetic markers are identified Follow-up care involves regular monitoring to detect recurrence and manage side effects of treatment. Supportive care services are also vital to enhance quality of life during and after treatment.
Clinical Advice & FAQs
Billing Guidance
Is C57.3 a billable ICD-10 code?
Yes, C57.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C57.3?
Clinical documentation must specify the nature of Malignant neoplasm of parametrium and any associated comorbidities for accurate reporting.
Cite this Clinical Reference